{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:23:40Z","timestamp":1792801420594,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071841"],"award-info":[{"award-number":["82071841"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"2019 Discipline Development Project of Peking Union Medical College","award":["201920200106"],"award-info":[{"award-number":["201920200106"]}],"id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018609","name":"High-level Hospital Construction Project of Guangdong Provincial People's Hospital","doi-asserted-by":"publisher","award":["2022-PUMCH-B-044"],"award-info":[{"award-number":["2022-PUMCH-B-044"]}],"id":[{"id":"10.13039\/501100018609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The hyper-IgE syndromes (HIES) are a heterogeneous group of inborn errors of immunity-sharing manifestations including increased infection susceptibility, eczema, and raised serum IgE. Pulmonary complications are responsible for high morbidity and mortality rates in patients with HIES. This study examines the progression of pulmonary disease in adult patients with HIES and compares the subsequent findings with existing literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ten adult patients with HIES diagnosed at Peking Union Medical College Hospital (PUMCH) from January 2016 to October 2023 were included in this study. Diagnosis was confirmed using the National Institutes of Health (NIH) criteria and whole-exome sequencing. Clinical data on pulmonary disease progression, microbiology, imaging and histology were collected. A systematic literature review was conducted for comparison.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Recurrent pulmonary infections led to significant structural lung damage, with 90.0% (9\/10) of patients developing bronchiectasis and pneumatocele. Early infections (0-10\u00a0years) were predominantly due to\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (80.0%,8\/10), while later stages (6-22\u00a0years) showed a shift to more complex infections with\n                      <jats:italic>Aspergillus<\/jats:italic>\n                      \/fungus (70.0%,7\/10),\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      (50.0%, 5\/10), and\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      (40.0%, 4\/10). Imaging revealed extensive bronchiectasis and pneumatocele formation. Histological examinations demonstrated acute inflammation (40%, 2\/5), granuloma formation (80%, 4\/5), and eosinophilic infiltration (100%, 5\/5). Comparatively, our findings are consistent with previous reports that suggest a higher incidence of pulmonary structural damage in patients with the signal transducer and activator of the transcription 3 (\n                      <jats:italic>STAT3<\/jats:italic>\n                      ) mutations than in those with other gene variants. However, our cohort showed a faster progression from initial infection to structural damage, highlighting the need for early intervention.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The progression of pulmonary disease in HIES patients underscores a critical three-step process: initial recurrent infections, development of structural lung damage, and subsequent reinfections that aggravate the damage. This rapid transition from infection to structural damage, especially in patients with\n                      <jats:italic>STAT3<\/jats:italic>\n                      mutations, highlights the importance of early and aggressive intervention. Managing reinfections after structural lung damage is essential to prevent further deterioration and to improve long-term outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03749-6","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:12:25Z","timestamp":1748927545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pulmonary features and stage of disease in adult patients with hyper-IgE syndrome: a single-centre clinical study and literature review"],"prefix":"10.1186","volume":"20","author":[{"given":"Tiange","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingdong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Di","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6373-0647","authenticated-orcid":false,"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"7157","key":"3749_CR1","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, Kawamura N, Ariga T, Pasic S, Stojkovic O, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448(7157):1058\u201362.","journal-title":"Nature"},{"issue":"16","key":"3749_CR2","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, Freeman AF, Demidowich A, Davis J, Turner ML, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608\u201319.","journal-title":"N Engl J Med"},{"issue":"1","key":"3749_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jaci.2008.04.037","volume":"122","author":"ED Renner","year":"2008","unstructured":"Renner ED, Rylaarsdam S, Anover-Sombke S, Rack AL, Reichenbach J, Carey JC, Zhu Q, Jansson AF, Barboza J, Schimke LF, et al. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J Allergy Clin Immunol. 2008;122(1):181\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"3749_CR4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202592","author":"T Asano","year":"2021","unstructured":"Asano T, Khourieh J, Zhang P, Rapaport F, Spaan AN, Li J, Lei W-T, Pelham SJ, Hum D, Chrabieh M, et al. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20202592.","journal-title":"J Exp Med"},{"key":"3749_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.10.059","author":"C Woellner","year":"2010","unstructured":"Woellner C, Gertz EM, Sch\u00e4ffer AA, Lagos M, Perro M, Glocker E-O, Pietrogrande MC, Cossu F, Franco JL, Matamoros N, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010. https:\/\/doi.org\/10.1016\/j.jaci.2009.10.059.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"3749_CR6","volume":"2","author":"TH Mogensen","year":"2013","unstructured":"Mogensen TH. STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties. JAKSTAT. 2013;2(2): e23435.","journal-title":"JAKSTAT"},{"key":"3749_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31825f95b9","author":"M-O Chandesris","year":"2012","unstructured":"Chandesris M-O, Melki I, Natividad A, Puel A, Fieschi C, Yun L, Thumerelle C, Oksenhendler E, Boutboul D, Thomas C, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Med (Baltimore). 2012. https:\/\/doi.org\/10.1097\/MD.0b013e31825f95b9.","journal-title":"Med (Baltimore)"},{"issue":"9","key":"3749_CR8","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/all.13753","volume":"74","author":"C Kr\u00f6ner","year":"2019","unstructured":"Kr\u00f6ner C, Neumann J, Ley-Zaporozhan J, Hagl B, Meixner I, Spielberger BD, D\u00fcckers G, Belohradsky BH, Niehues T, Borte M, et al. Lung disease in STAT3 hyper-IgE syndrome requires intense therapy. Allergy. 2019;74(9):1691\u2013702.","journal-title":"Allergy"},{"issue":"4","key":"3749_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.alit.2021.07.007","volume":"70","author":"Y Minegishi","year":"2021","unstructured":"Minegishi Y. Hyper-IgE syndrome, 2021 update. Allergol Int. 2021;70(4):407\u201314.","journal-title":"Allergol Int"},{"issue":"3","key":"3749_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ccm.2016.04.016","volume":"37","author":"AF Freeman","year":"2016","unstructured":"Freeman AF, Olivier KN. Hyper-IgE Syndromes and the Lung. Clin Chest Med. 2016;37(3):557\u201367.","journal-title":"Clin Chest Med"},{"issue":"2","key":"3749_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jaci.2023.06.003","volume":"152","author":"EA Gilje","year":"2023","unstructured":"Gilje EA, Abbott JK. The pulmonary effects of STAT3 deficiency. J Allergy Clin Immunol. 2023;152(2):368\u201370.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"3749_CR12","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jaci.2022.12.821","volume":"152","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Lin T, Leung HM, Zhang C, Wilson-Mifsud B, Feldman MB, Puel A, Lanternier F, Couderc L-J, Danion F, et al. STAT3 mutation-associated airway epithelial defects in Job syndrome. J Allergy Clin Immunol. 2023;152(2):538\u201350.","journal-title":"J Allergy Clin Immunol"},{"issue":"7445","key":"3749_CR13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","volume":"1","author":"SD Davis","year":"1966","unstructured":"Davis SD, Schaller J, Wedgwood RJ. Job\u2019s Syndrome Recurrent, \u201ccold\u201d, staphylococcal abscesses. Lancet. 1966;1(7445):1013\u20135.","journal-title":"Lancet"},{"key":"3749_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.06.041","author":"Y Gernez","year":"2018","unstructured":"Gernez Y, Freeman AF, Holland SM, Garabedian E, Patel NC, Puck JM, Sullivan KE, Akhter J, Secord E, Chen K, et al. Autosomal dominant Hyper-IgE syndrome in the USIDNET Registry. J Allergy Clin Immunol Pract. 2018. https:\/\/doi.org\/10.1016\/j.jaip.2017.06.041.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3749_CR15","first-page":"302","volume":"05","author":"WD Yun Li","year":"1984","unstructured":"Yun Li WD, Xiong W. A case report of Hyperige syndrome. Shanghai J Immunol. 1984;05:302\u20133.","journal-title":"Shanghai J Immunol"},{"issue":"2","key":"3749_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10875-017-0369-7","volume":"37","author":"J Wu","year":"2017","unstructured":"Wu J, Chen J, Tian Z-Q, Zhang H, Gong R-L, Chen T-X, Hong L. Clinical Manifestations and genetic analysis of 17 Patients with autosomal dominant hyper-IgE syndrome in mainland china: new reports and a literature review. J Clin Immunol. 2017;37(2):166\u201379.","journal-title":"J Clin Immunol"},{"key":"3749_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13223-020-00462-w","volume":"16","author":"L Lin","year":"2020","unstructured":"Lin L, Wang Y, Sun B, Liu L, Ying W, Wang W, Zhou Q, Hou J, Yao H, Hu L, et al. The clinical, immunological and genetic features of 12 Chinese patients with STAT3 mutations. Allergy Asthma Clin Immunol. 2020;16:65.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"12","key":"3749_CR18","first-page":"955","volume":"16","author":"HF Na Xu","year":"2017","unstructured":"Na Xu HF, Zhao J, Wang P, Song H, Zeng X. Hyper-IgE Syndromes in adults: report of 5 cases and literature review. Chinese J Gen Pract. 2017;16(12):955\u201360.","journal-title":"Chinese J Gen Pract"},{"issue":"3","key":"3749_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1086\/302547","volume":"65","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Sch\u00e4ffer AA, Holland SM, Davis J, Gallin JI, Malech HL, Atkinson TP, Belohradsky BH, Buckley RH, Cossu F, et al. Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet. 1999;65(3):735\u201344.","journal-title":"Am J Hum Genet"},{"key":"3749_CR20","unstructured":"ClinVar. http:\/\/www.ncbi.nlm.nih.gov\/clinvar. Accessed 4 April 2025."},{"key":"3749_CR21","unstructured":"OMIM. http:\/\/www.omim.org. Accessed 4 April 2025."},{"key":"3749_CR22","unstructured":"Human Gene Mutation Database. http:\/\/www.hgmd.org. Accessed 4 April 2025."},{"key":"3749_CR23","unstructured":"SIFT. http:\/\/sift.jcvi.org. Accessed 4 April 2025."},{"key":"3749_CR24","unstructured":"Polymorphism Phenotyping v2. http:\/\/genetics.bwh.harvard.edu\/pph2. Accessed 4 April 2025."},{"key":"3749_CR25","unstructured":"Combined Annotation Dependent Depletion. http:\/\/cadd.gs.washington.edu. Accessed 4 April 2025."},{"key":"3749_CR26","unstructured":"MutationTaster. http:\/\/www.mutationtaster.org. Accessed 4 April 2025."},{"issue":"5","key":"3749_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"7","key":"3749_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.","journal-title":"PLoS Med"},{"issue":"3","key":"3749_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1034\/j.1399-3038.2000.00091.x","volume":"11","author":"MD Erlewyn-Lajeunesse","year":"2000","unstructured":"Erlewyn-Lajeunesse MD. Hyperimmunoglobulin-E syndrome with recurrent infection: a review of current opinion and treatment. Pediatr Allergy Immunol. 2000;11(3):133\u201341.","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"3749_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0091-6749(95)70185-0","volume":"95","author":"H Kimata","year":"1995","unstructured":"Kimata H. High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome. J Allergy Clin Immunol. 1995;95(3):771\u20134.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"3749_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1081-1206(10)60424-3","volume":"100","author":"K Bork","year":"2008","unstructured":"Bork K, Bygum A, Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients. Ann Allergy Asthma Immunol. 2008;100(2):153\u201361.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"3749_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s10875-017-0429-z","volume":"37","author":"M Arora","year":"2017","unstructured":"Arora M, Bagi P, Strongin A, Heimall J, Zhao X, Lawrence MG, Trivedi A, Henderson C, Hsu A, Quezado M, et al. Gastrointestinal manifestations of STAT3-Deficient Hyper-IgE Syndrome. J Clin Immunol. 2017;37(7):695\u2013700.","journal-title":"J Clin Immunol"},{"issue":"12","key":"3749_CR33","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1002\/eji.201847650","volume":"48","author":"S Farmand","year":"2018","unstructured":"Farmand S, Kremer B, H\u00e4ffner M, P\u00fctsep K, Bergman P, Sundin M, Ritterbusch H, Seidl M, Follo M, Henneke P, et al. Eosinophilia and reduced STAT3 signaling affect neutrophil cell death in autosomal-dominant Hyper-IgE syndrome. Eur J Immunol. 2018;48(12):1975\u201388.","journal-title":"Eur J Immunol"},{"issue":"2","key":"3749_CR34","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.aller.2018.07.009","volume":"47","author":"S Alyasin","year":"2019","unstructured":"Alyasin S, Esmaeilzadeh H, Ebrahimi N, Nabavizadeh SH, Kashef S, Esmaeilzadeh E, Babaei M, Amin R. Phenotyping and long-term follow up of patients with hyper IgE syndrome. Allergol Immunopathol (Madr). 2019;47(2):152\u20138.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"4","key":"3749_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/pai.13043","volume":"30","author":"M Tavassoli","year":"2019","unstructured":"Tavassoli M, Abolhassani H, Yazdani R, Ghadami M, Azizi G, Abdolrahim Poor Heravi S, Moeini Shad T, Kokabee M, Movahedi M, Abdshahzadeh H, et al. The first cohort of Iranian patients with hyper immunoglobulin E syndrome: a long-term follow-up and genetic analysis. Pediatr Allergy Immunol. 2019;30(4):469\u201378.","journal-title":"Pediatr Allergy Immunol"},{"key":"3749_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.02.012","author":"T Lorenzini","year":"2019","unstructured":"Lorenzini T, Giacomelli M, Scomodon O, Cortesi M, Rivellini V, Dotta L, Soresina A, Dellepiane RM, Carrabba M, Cossu F, et al. Autosomal-dominant hyper-IgE syndrome is associated with appearance of infections early in life and\/or neonatal rash: Evidence from the Italian cohort of 61 patients with elevated IgE. J Allergy Clin Immunol Pract. 2019. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.012.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"33","key":"3749_CR37","doi-asserted-by":"publisher","first-page":"16463","DOI":"10.1073\/pnas.1901409116","volume":"116","author":"J Khourieh","year":"2019","unstructured":"Khourieh J, Rao G, Habib T, Avery DT, Lef\u00e8vre-Utile A, Chandesris M-O, Belkadi A, Chrabieh M, Alwaseem H, Grandin V, et al. A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance. Proc Natl Acad Sci U S A. 2019;116(33):16463\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3749_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12885","volume":"91","author":"Q Xiang","year":"2020","unstructured":"Xiang Q, Zhang L, Liu X, Wang S, Wang T, Xiao M, Zhao X, Jiang L. Autosomal dominant hyper IgE syndrome from a single centre in Chongqing, China (2009\u20132018). Scand J Immunol. 2020;91(6): e12885.","journal-title":"Scand J Immunol"},{"key":"3749_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626593","volume":"12","author":"B Saikia","year":"2021","unstructured":"Saikia B, Rawat A, Minz RW, Suri D, Pandiarajan V, Jindal A, Sahu S, Karim A, Desai M, Taur PD, et al. Clinical profile of hyper-IgE syndrome in India. Front Immunol. 2021;12: 626593.","journal-title":"Front Immunol"},{"issue":"8","key":"3749_CR40","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1007\/s10875-021-01086-4","volume":"41","author":"N Frede","year":"2021","unstructured":"Frede N, Rojas-Restrepo J, Garcia C, de Oteyza A, Buchta M, H\u00fcbscher K, G\u00e1mez-D\u00edaz L, Proietti M, Saghafi S, Chavoshzadeh Z, Soler-Palacin P, et al. Genetic analysis of a cohort of 275 patients with hyper-IgE syndromes and\/or chronic Mucocutaneous Candidiasis. J Clin Immunol. 2021;41(8):1804\u201338.","journal-title":"J Clin Immunol"},{"key":"3749_CR41","doi-asserted-by":"publisher","first-page":"1044933","DOI":"10.3389\/fimmu.2022.1044933","volume":"13","author":"O Shamriz","year":"2022","unstructured":"Shamriz O, Rubin L, Simon AJ, Lev A, Barel O, Somech R, Korem M, MatzaPorges S, Freund T, Hagin D, et al. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: a single center experience. Front Immunol. 2022;13:1044933.","journal-title":"Front Immunol"},{"key":"3749_CR42","doi-asserted-by":"publisher","first-page":"1057679","DOI":"10.3389\/fimmu.2022.1057679","volume":"13","author":"R Yaakoubi","year":"2022","unstructured":"Yaakoubi R, Mekki N, Ben-Mustapha I, Ben-Khemis L, Bouaziz A, Ben Fraj I, Ammar J, Hamzaoui A, Turki H, Boussofara L, et al. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes. Front Immunol. 2022;13:1057679.","journal-title":"Front Immunol"},{"key":"3749_CR43","doi-asserted-by":"crossref","unstructured":"2018 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference. J Clin Immunol 2018, 38(3):330-444","DOI":"10.1007\/s10875-018-0485-z"},{"issue":"1","key":"3749_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13223-023-00776-5","volume":"19","author":"M Carrabba","year":"2023","unstructured":"Carrabba M, Dellepiane RM, Cortesi M, Baselli LA, Soresina A, Cirillo E, Giardino G, Conti F, Dotta L, Finocchi A, et al. Long term longitudinal follow-up of an AD-HIES cohort: the impact of early diagnosis and enrollment to IPINet centers on the natural history of Job\u2019s syndrome. Allergy Asthma Clin Immunol. 2023;19(1):32.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"Suppl 55","key":"3749_CR45","volume":"38","author":"H Dmenska","year":"2011","unstructured":"Dmenska H, Heropolitanska E, Pietrucha B, Bernatowska E. Pulmonary features of autosomal dominant hyper-IgE syndrome [AD HIES]. Eur Respir J. 2011;38(Suppl 55): p3600.","journal-title":"Eur Respir J"},{"key":"3749_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.02.041","author":"A Dur\u00e9ault","year":"2019","unstructured":"Dur\u00e9ault A, Tcherakian C, Poiree S, Catherinot E, Danion F, Jouvion G, Bougnoux ME, Mahlaoui N, Givel C, Castelle M, et al. Spectrum of Pulmonary aspergillosis in hyper-IgE syndrome with autosomal-dominant STAT3 deficiency. J Allergy Clin Immunol Pract. 2019. https:\/\/doi.org\/10.1016\/j.jaip.2019.02.041.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"3749_CR47","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s10875-013-9890-5","volume":"33","author":"AF Freeman","year":"2013","unstructured":"Freeman AF, Renner ED, Henderson C, Langenbeck A, Olivier KN, Hsu AP, Hagl B, Boos A, Davis J, Marciano BE, et al. Lung parenchyma surgery in autosomal dominant hyper-IgE syndrome. J Clin Immunol. 2013;33(5):896\u2013902.","journal-title":"J Clin Immunol"},{"issue":"1","key":"3749_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12893-023-02193-2","volume":"23","author":"SA Mahdaviani","year":"2023","unstructured":"Mahdaviani SA, Ghadimi S, Fallahi M, Hashemi-Moghaddam SA, Chavoshzadeh Z, Puel A, Rezaei N, Rekabi M, Daneshmandi Z, Sheikhy K, et al. Interventional pulmonary procedures and their outcomes in patients with STAT3 hyper IgE syndrome. BMC Surg. 2023;23(1):289.","journal-title":"BMC Surg"},{"key":"3749_CR49","unstructured":"Urban AK, Darnell D, Peterson J, Welch P, Freeman AF, Olivier KN: Characterization of Lung Disease in Autosomal Dominant Hyper IgE Syndrome. In: C35 CLINICAL STUDIES IN IMMUNODEFICIENCY. Edn.: A4797-4797."},{"issue":"3","key":"3749_CR50","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3324\/haematol.2018.194233","volume":"104","author":"T Shahin","year":"2019","unstructured":"Shahin T, Aschenbrenner D, Cagdas D, Bal SK, Conde CD, Garncarz W, Medgyesi D, Schwerd T, Karaatmaca B, Cetinkaya PG, et al. Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function. Haematologica. 2019;104(3):609\u201321.","journal-title":"Haematologica"},{"key":"3749_CR51","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191804","author":"V B\u00e9ziat","year":"2020","unstructured":"B\u00e9ziat V, Tavernier SJ, Chen Y-H, Ma CS, Materna M, Laurence A, Staal J, Aschenbrenner D, Roels L, Worley L, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20191804.","journal-title":"J Exp Med"},{"key":"3749_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.02.025","author":"A Sassi","year":"2014","unstructured":"Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, Patiroglu T, Unal E, Ozdemir MA, Jouhadi Z, et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol. 2014. https:\/\/doi.org\/10.1016\/j.jaci.2014.02.025.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"3749_CR53","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/ng.3898","volume":"49","author":"CA Ma","year":"2017","unstructured":"Ma CA, Stinson JR, Zhang Y, Abbott JK, Weinreich MA, Hauk PJ, Reynolds PR, Lyons JJ, Nelson CG, Ruffo E, et al. Germline hypomorphic CARD11 mutations in severe atopic disease. Nat Genet. 2017;49(8):1192\u2013201.","journal-title":"Nat Genet"},{"issue":"5","key":"3749_CR54","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.immuni.2006.09.009","volume":"25","author":"Y Minegishi","year":"2006","unstructured":"Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity. 2006;25(5):745\u201355.","journal-title":"Immunity"},{"issue":"3","key":"3749_CR55","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1084\/jem.20161435","volume":"214","author":"JJ Lyons","year":"2017","unstructured":"Lyons JJ, Liu Y, Ma CA, Yu X, O\u2019Connell MP, Lawrence MG, Zhang Y, Karpe K, Zhao M, Siegel AM, et al. ERBIN deficiency links STAT3 and TGF-\u03b2 pathway defects with atopy in humans. J Exp Med. 2017;214(3):669\u201380.","journal-title":"J Exp Med"},{"issue":"9","key":"3749_CR56","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJM199903043400904","volume":"340","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O\u2019Connell AC, Puck JM. Hyper-IgE syndrome with recurrent infections\u2013an autosomal dominant multisystem disorder. N Engl J Med. 1999;340(9):692\u2013702.","journal-title":"N Engl J Med"},{"key":"3749_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2016.05.001","author":"EJ Hillmer","year":"2016","unstructured":"Hillmer EJ, Zhang H, Li HS, Watowich SS. STAT3 signaling in immunity. Cytokine Growth Factor Rev. 2016. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.05.001.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5332","key":"3749_CR58","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell","year":"1997","unstructured":"Darnell JE. STATs and gene regulation. Science. 1997;277(5332):1630\u20135.","journal-title":"Science"},{"issue":"2","key":"3749_CR59","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/intimm\/dxn134","volume":"21","author":"Y Minegishi","year":"2009","unstructured":"Minegishi Y, Karasuyama H. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int Immunol. 2009;21(2):105\u201312.","journal-title":"Int Immunol"},{"issue":"7881","key":"3749_CR60","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0140-6736(74)91942-4","volume":"2","author":"HR Hill","year":"1974","unstructured":"Hill HR, Ochs HD, Quie PG, Clark RA, Pabst HF, Klebanoff SJ, Wedgwood RJ. Defect in neutrophil granulocyte chemotaxis in Job\u2019s syndrome of recurrent \u201ccold\u201d staphylococcal abscesses. Lancet. 1974;2(7881):617\u20139.","journal-title":"Lancet"},{"key":"3749_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.04.001","author":"HD Ochs","year":"2009","unstructured":"Ochs HD, Oukka M, Torgerson TR. TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol. 2009. https:\/\/doi.org\/10.1016\/j.jaci.2009.04.001.","journal-title":"J Allergy Clin Immunol"},{"issue":"7850","key":"3749_CR62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(74)92493-3","volume":"1","author":"HR Hill","year":"1974","unstructured":"Hill HR, Quie PG. Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet. 1974;1(7850):183\u20137.","journal-title":"Lancet"},{"issue":"6","key":"3749_CR63","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1084\/jem.20082767","volume":"206","author":"Y Minegishi","year":"2009","unstructured":"Minegishi Y, Saito M, Nagasawa M, Takada H, Hara T, Tsuchiya S, Agematsu K, Yamada M, Kawamura N, Ariga T, et al. Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med. 2009;206(6):1291\u2013301.","journal-title":"J Exp Med"},{"issue":"35","key":"3749_CR64","doi-asserted-by":"publisher","first-page":"E3641","DOI":"10.1073\/pnas.1409781111","volume":"111","author":"T Tadokoro","year":"2014","unstructured":"Tadokoro T, Wang Y, Barak LS, Bai Y, Randell SH, Hogan BLM. IL-6\/STAT3 promotes regeneration of airway ciliated cells from basal stem cells. Proc Natl Acad Sci U S A. 2014;111(35):E3641\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3749_CR65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1172\/JCI19491","volume":"113","author":"I Hokuto","year":"2004","unstructured":"Hokuto I, Ikegami M, Yoshida M, Takeda K, Akira S. Stat-3 is required for pulmonary homeostasis during hyperoxia. J Clin Invest. 2004;113(1):28\u201337.","journal-title":"J Clin Invest"},{"issue":"17\u201318","key":"3749_CR66","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1089\/hum.2020.160","volume":"31","author":"NE King","year":"2020","unstructured":"King NE, Suzuki S, Barill\u00e0 C, Hawkins FJ, Randell SH, Reynolds SD, Stripp BR, Davis BR. Correction of airway stem cells: genome editing approaches for the treatment of cystic fibrosis. Hum Gene Ther. 2020;31(17\u201318):956\u201372.","journal-title":"Hum Gene Ther"},{"issue":"7","key":"3749_CR67","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1016\/j.ymthe.2020.04.021","volume":"28","author":"S Suzuki","year":"2020","unstructured":"Suzuki S, Crane AM, Anirudhan V, Barill\u00e0 C, Matthias N, Randell SH, Rab A, Sorscher EJ, Kerschner JL, Yin S, et al. Highly efficient gene editing of cystic fibrosis patient-derived airway basal cells results in functional CFTR correction. Mol Ther. 2020;28(7):1684\u201395.","journal-title":"Mol Ther"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03749-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03749-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:02:16Z","timestamp":1748930536000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03749-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3749"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03749-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5618843\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of PUMCH and conducted in compliance with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}